33 results match your criteria: "and The University of Miami Miller School of Medicine[Affiliation]"

Design, characterisation, and clinical evaluation of a novel porous Ti-6Al-4V hemipelvic prosthesis based on Voronoi diagram.

Biomater Transl

September 2024

Orthopaedic Research Institute and Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.

Three-dimensional printed Ti-6Al-4V hemipelvic prosthesis has become a current popular method for pelvic defect reconstruction. This paper presents a novel biomimetic hemipelvic prosthesis design that utilises patient-specific anatomical data in conjunction with the Voronoi diagram algorithm. Unlike traditional design methods that rely on fixed, homogeneous unit cell, the Voronoi diagram enables to create imitation of trabecular structure (ITS).

View Article and Find Full Text PDF

Advances in the molecular biology of the solitary fibrous tumor and potential impact on clinical applications.

Cancer Metastasis Rev

December 2024

Department of Orthopedic Surgery, Sarcoma Biology Laboratory, Sylvester Comprehensive Cancer Center, and the University of Miami Miller School of Medicine, Papanicolaou Cancer Research Building, 1550 NW. 10Th Avenue, Miami, FL, 33136, USA.

Article Synopsis
  • * The SFT consists of spindle-shaped cells with a unique structure and is mainly diagnosed through methods such as RT-PCR and next-generation sequencing, which have their own strengths and weaknesses.
  • * Treatments for SFT include traditional options like surgery and radiation, but new approaches are emerging, including immunotherapy and targeted therapies, which may improve patient outcomes.
View Article and Find Full Text PDF

CDK12 is a promising therapeutic target for the transcription cycle and DNA damage response in metastatic osteosarcoma.

Carcinogenesis

October 2024

Sarcoma Biology Laboratory, Department of Orthopaedics, Sylvester Comprehensive Cancer Center, and the University of Miami Miller School of Medicine, Miami, FL, 33136USA.

Article Synopsis
  • - Osteosarcoma (OS) is a malignant bone tumor primarily affecting younger individuals and is currently treated with outdated chemotherapy methods, highlighting the need for new treatment strategies.
  • - The study investigates the role of cyclin-dependent kinase 12 (CDK12) in osteosarcoma, finding that high CDK12 levels are linked to aggressive tumors and poorer patient survival.
  • - Results show that inhibiting CDK12 decreases cancer cell growth and promotes apoptosis, indicating that CDK12 could serve as a promising biomarker and therapeutic target for treating metastatic osteosarcoma.
View Article and Find Full Text PDF

Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma.

Biochem Pharmacol

August 2024

Department of Orthopedic Surgery, Sarcoma Biology Laboratory, Sylvester Comprehensive Cancer Center, and the University of Miami Miller School of Medicine, Papanicolaou Cancer Research Building, 1550 N.W. 10(th) Avenue, Miami, FL 33136. USA. Electronic address:

Sarcomas include various subtypes comprising two significant groups - soft tissue and bone sarcomas. Although the survival rate for some sarcoma subtypes has improved over time, the current methods of treatment remain efficaciously limited, as recurrent, and metastatic diseases remain a major obstacle. There is a need for better options and therapeutic strategies in treating sarcoma.

View Article and Find Full Text PDF

Objective: Surgery for primary tumors of the mobile spine and sacrum often requires complex reconstruction techniques to cover soft-tissue defects and to treat wound and CSF-related complications. The anatomical, vascular, and immunoregulatory characteristics of the omentum make it an excellent local substrate for the management of radiation soft-tissue injury, infection, and extensive wound defects. This study describes the authors' experience in complex wound reconstruction using pedicled omental flaps to cover defects in surgery for mobile spine and sacral primary tumors.

View Article and Find Full Text PDF

Erratum: ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage.

Am J Cancer Res

October 2023

Department of Orthopedic Surgery, Sarcoma Biology Laboratory, Sylvester Comprehensive Cancer Center, and The University of Miami Miller School of Medicine, Papanicolaou Cancer Research Building 1550 NW. 10th Avenue, Miami, Florida 33136, USA.

[This corrects the article on p. 1577 in vol. 12, PMID: 35530299.

View Article and Find Full Text PDF

Background: Liposarcoma is the most commonly diagnosed subtype of soft tissue sarcoma. As these tumors often arise near vital organs and neurovascular structures, complete resection can be challenging; consequently, recurrence rates are high. Additionally, available chemotherapeutic agents have shown limited benefit and substantial toxicities.

View Article and Find Full Text PDF

Comparison of Antiretroviral Therapies in Pregnant Women Living With Human Immunodeficiency Virus and Hepatitis B Virus: A Randomized Controlled Trial.

Obstet Gynecol

September 2023

David Geffen School of Medicine at UCLA, Los Angeles, California; the Harvard T.H. Chan School of Public Health, Boston, Massachusetts; the MU-JHU Research Collaboration and the Makerere University School of Public Health, Kampala, Uganda; Caprisa-University of Kwazulu-Natal and the University of Kwazulu-Natal, Durban, South Africa; the Uz-UCSF Collaborative Research Programme, Harare, Zimbabwe; the Johns Hopkins Research Project, Blantyre, Malawi; Fhi 360, Durham, North Carolina; the National Institutes of Health, Bethesda, Maryland; Johns Hopkins University, Baltimore, Maryland; the University of California, San Francisco, San Francisco, California; and the University of Miami Miller School of Medicine, Miami, Florida.

Objective: To describe the anti-hepatitis B virus (HBV) efficacy, HBeAg serologic changes, HBV perinatal transmission, and safety in pregnant women who are living with human immunodeficiency virus (HIV) and HBV co-infection who were randomized to various antiretroviral therapy (ART) regimens.

Methods: The PROMISE (Promoting Maternal and Infant Survival Everywhere) trial was a multicenter randomized trial for ART-naive pregnant women with HIV infection. Women with HIV and HBV co-infection at 14 or more weeks of gestation were randomized to one of three ART arms: one without HBV treatment (group 1) and two HBV treatment arms with single (group 2) or dual anti-HBV activity (group 3).

View Article and Find Full Text PDF

Exosomes in the tumor microenvironment of sarcoma: from biological functions to clinical applications.

J Nanobiotechnology

September 2022

Orthopedic Research Institute, Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, China.

Article Synopsis
  • Doctors are having a hard time diagnosing and treating a type of cancer called sarcoma quickly and effectively.
  • Scientists are looking at the tumor microenvironment (TME), which includes different cells and tiny particles called exosomes that help cancer grow and spread.
  • Exosomes could be useful in finding and treating sarcoma because they have special features that make them good for testing and delivering treatments.
View Article and Find Full Text PDF

EVs have emerged as an important component in tumour initiation, progression and metastasis. Although notable progresses have been made, the detection of EV cargoes remain significantly challenging for researchers to practically use; faster and more convenient methods are required to validate the EV cargoes, especially as biomarkers. Here we show, the possibility of examining embedded EVs as substrates to be used for detecting DNA amplification through ultrasensitive in situ hybridization (ISH).

View Article and Find Full Text PDF

Hereditary cancer syndromes comprise an important subset of cancers caused by pathogenic germline mutations that can affect various organ systems. Radiologic screening and surveillance for solid tumors has emerged as a critical component of patient management in permitting early cancer detection. Although imaging surveillance may be tailored for organ-specific cancer risks, surveillance protocols frequently utilize whole-body MRI or PET/CT because of their ability to identify neoplasms in different anatomic regions in a single exam.

View Article and Find Full Text PDF

Single-Dose, Bioadhesive Clindamycin 2% Gel for Bacterial Vaginosis: A Randomized Controlled Trial.

Obstet Gynecol

June 2022

Daré Bioscience, Inc., San Diego, California; the University of Pittsburgh and Magee-Womens Research Institute, Pittsburgh, Pennsylvania; Gendreau Consulting, LLC, Poway, California; Health Decisions, Inc., Durham, North Carolina; Segal Trials and the University of Miami Miller School of Medicine, Miami, Florida; Precision Trials AZ, LLC, Phoenix, Arizona; Praetorian Pharmaceutical Research and West Jefferson Medical Center, Marrero, Louisiana; Southern Clinical Research Associates, LLC, Metairie, Louisiana; and TMC Life Research, Inc., Houston, Texas.

Objective: To assess efficacy and safety of a single-dose vaginal clindamycin gel for bacterial vaginosis treatment.

Methods: We conducted a double-blind, placebo-controlled, randomized study comparing clindamycin gel with placebo (2:1 ratio). Entry required clinical diagnosis of bacterial vaginosis, that is, all four Amsel's criteria, without other genital infections.

View Article and Find Full Text PDF

ATR inhibition sensitizes liposarcoma to doxorubicin by increasing DNA damage.

Am J Cancer Res

April 2022

Department of Orthopedic Surgery, Sarcoma Biology Laboratory, Sylvester Comprehensive Cancer Center, and The University of Miami Miller School of Medicine, Papanicolaou Cancer Research Building 1550 NW. 10th Avenue, Miami, Florida 33136, USA.

Article Synopsis
  • * Researchers studied a protein called ATR to see how it works in liposarcoma and found that most samples had a lot of it, which was linked to shorter survival for patients.
  • * They discovered that blocking ATR helped slow down the growth and spread of liposarcoma cells, and made them more sensitive to the chemotherapy drug doxorubicin, suggesting a new treatment approach.
View Article and Find Full Text PDF

Inhibition of CDK7-dependent transcriptional addiction is a potential therapeutic target in synovial sarcoma.

Biomed Pharmacother

May 2022

Sarcoma Biology Laboratory, Department of Orthopaedics, Sylvester Comprehensive Cancer Center, and the University of Miami Miller School of Medicine, Miami, Florida 33136, USA; Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, 90095, USA. Electronic address:

Synovial sarcoma is typical aggressive malignant without satisfactory treatment outcome in adult series. Cyclin-dependent kinases (CDKs) in transcription have been considered promising molecular targets in cancer. Among these, CDK7 has been shown to play important roles in the pathogenesis of malignancies.

View Article and Find Full Text PDF

SMARCB1 expression is a novel diagnostic and prognostic biomarker for osteosarcoma.

Biosci Rep

January 2022

Department of Orthopedic Surgery, Sarcoma Biology Laboratory, Sylvester Comprehensive Cancer Center, and The University of Miami Miller School of Medicine. Address: Papanicolaou Cancer Research Building, 1550 NW. 10th Avenue, Miami, FL 33136, U.S.A.

Background: Although weak SWI/SNF related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (SMARCB1) expression is a known diagnostic and prognostic biomarker in several malignancies, its expression and clinical significance in osteosarcoma remain unknown. The aim of the present study was to investigate SMARCB1 expression in osteosarcoma and its clinical significance with respect to chemosensitivity and prognosis.

Methods: We obtained 114 specimens from 70 osteosarcoma patients to construct a tissue microarray (TMA) and assess SMARCB1 protein expression via immunohistochemistry (IHC).

View Article and Find Full Text PDF

Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.

Cancer Control

January 2022

Sarcoma Biology Laboratory, Department of Orthopaedics, Sylvester Comprehensive Cancer Center, and the University of Miami Miller School of Medicine, Miami, FL 33136.

Background: The dedifferentiated variant of chondrosarcoma is highly aggressive and carries an especially grim prognosis. While chemotherapeutics has failed to benefit patients with dedifferentiated chondrosarcoma significantly, preclinical chemosensitivity studies have been limited by a scarcity of available cell lines. There is, therefore, an urgent need to expand the pool of available cell lines.

View Article and Find Full Text PDF

MRI Volumetrics and Image Texture Analysis in Assessing Systemic Treatment Response in Extra-Abdominal Desmoid Fibromatosis.

Radiol Imaging Cancer

July 2021

From the Departments of Radiology (T.K.S., N.A.), Pathology (A.R.), and Medicine-Medical Oncology (J.T., B.A.W.), Sylvester Comprehensive Cancer Center and the University of Miami Miller School of Medicine/Jackson Memorial Hospital, 1611 NW 12th Ave, JMH WW 279, Miami, FL 33136; Department of Radiology, University of Miami Miller School of Medicine, Miami, Fla (K.F., K.S.); and Department of Public Health Sciences, Sylvester Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, Fla (D.K.).

Purpose To determine whether MRI volumetric and image texture analysis correlates with treatment-induced biologic changes in desmoid fibromatosis (DF) earlier than conventional response criteria. Materials and Methods This retrospective study included 27 patients with histologically proven extra-abdominal DF who were managed with active surveillance or systemic therapy (from 2004 to 2016). MRI volumetric and image texture parameters were derived from manual tumor segmentations, and tumor signal intensity was normalized to muscle.

View Article and Find Full Text PDF

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.

N Engl J Med

April 2021

From Baylor College of Medicine, Houston (I.O.R.); James J. Peters Veterans Affairs Medical Center, Bronx, and Icahn School of Medicine at Mount Sinai, New York - both in New York (N.B.); eStudy Site, Chula Vista (M.W.), Genentech, South San Francisco (M.B., L.T.), and the University of California, San Diego, La Jolla (A.M.) - all in California; Hackensack Meridian School of Medicine and Hacksensack University Medical Center, Hackensack, NJ (R.C.G.); Intermountain Healthcare, Salt Lake City (B.D.H.); Royal Free Hospital (S.B.) and Imperial College London (N.C., T.Y.), London, Leeds Teaching Hospitals NHS Trust and National Institute for Health Research-Leeds Biomedical Research Centre, Leeds (S.S.), North Manchester General Hospital, Manchester (A.U.), and Roche Products, Welwyn Garden City (S.D., E.G., B.M., H.S.) - all in the United Kingdom; the University of Massachusetts Medical School-Baystate, Springfield (D.S.); Rush University Medical Center, Chicago (M.S.A.); Denver Health Medical Center, Denver (I.S.D.), and the University of Colorado, Anschutz School of Medicine, Aurora (I.S.D.); University Health Network, Toronto (L.D.S.); Hospital Universitario HM Sanchinarro, Centro Integral, Oncológico Clara Campal and Departamento de Ciencias Médicas Clínicas, Facultad de Medicina, Universidad CEU San Pablo, Madrid (A.C.G.); and the University of Miami Miller School of Medicine, Miami (D.J.D.L.Z.).

Background: Coronavirus disease 2019 (Covid-19) is associated with immune dysregulation and hyperinflammation, including elevated interleukin-6 levels. The use of tocilizumab, a monoclonal antibody against the interleukin-6 receptor, has resulted in better outcomes in patients with severe Covid-19 pneumonia in case reports and retrospective observational cohort studies. Data are needed from randomized, placebo-controlled trials.

View Article and Find Full Text PDF

Fat embolism syndrome (FES) most commonly can occur after trauma in patients with long bone fractures. While the majority of FES cases present as a mild decrease in mental status, some may manifest as seizure activity. We describe a case of a young patient with traumatic fractures who developed FES leading to refractory status epilepticus and simultaneously required damage controlled orthopedic surgery.

View Article and Find Full Text PDF

Objectives: Thirty-day readmissions are common, serious, and costly. Most important, often they are preventable. The purpose of this quality improvement study was to evaluate an interdisciplinary, two-phase intervention to reduce 30-day readmissions among high-risk medical patients.

View Article and Find Full Text PDF